quantisnow
FeedTopReportsPricing
⌘K
Live feed
04:35:52·902d
FDARegulatory
Lannett Co Inc logo

FDA Approval for RABEPRAZOLE SODIUM issued to LANNETT CO INC

LCI· Lannett Co Inc
Health Care
Original source

Companies

  • LCI
    Lannett Co Inc
    Health Care

Recent analyst ratings

  • Aug 31UpdateRoth Capital$6.00

Related

  • FDA576d
    FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC
  • FDA616d
    FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC
  • FDA645d
    FDA Approval for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE issued to LANNETT CO INC
  • FDA685d
    FDA Approval for PREDNISOLONE issued to LANNETT CO INC
  • FDA763d
    FDA Approval for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE issued to LANNETT CO INC
  • FDA769d
    FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC
  • FDA784d
    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE issued to LANNETT CO INC
  • FDA792d
    FDA Approval for LISDEXAMFETAMINE DIMESYLATE issued to LANNETT CO INC
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022